Document is current
Any future updates will be listed below
-
Authors
Chaar, Abdelkader
Damianos, John
Rizwan, Rabia
Al-Nahhas, Houssam
Mansoor, Muhammad Sohail
Sharma, Prabin
Malik, Umer
Feuerstadt, Paul https://orcid.org/0000-0002-7643-9576
- License Information
-
More Information
Article History
Received: 21 February 2023
Accepted: 21 August 2023
First Online: 4 September 2023
Declarations
:
: PF receives research support from Rebiotix/Ferring, Vedanta, Finch, Pfizer and Adare Pharmaceuticals. PF is on the speakers bureau for Ferring, SERES and Takeda. PF serves as a consultant for Ferring/Rebiotix, SERES, Takeda and Sanofi.
: The Yale University School of Medicine Human Investigation Committee (i.e., institutional review board) approved the study with a waiver to obtain consent from the study subjects given the retrospective study design (HIC No. 1510016606).
